Previous 10 | Next 10 |
NEXI-001 data presented at ASCO 2023 demonstrates proof-of-concept in patients with relapsed AML after allogeneic hematopoietic cell transplantation (HCT) and refractory to additional chemotherapy or salvage treatments; one patient continues to show no evidence of disease at nine months P...
- Trial includes high risk AML patients that have relapsed post allo-HSCT and are refractory to salvage therapy - NEXI-001 is well tolerated with a favorable safety profile, including no grade > 3 treatment related events as of May 2023 - Robust immune response with...
AIM nanoparticle approach can identify select EBV-specific T cell defects in patients with multiple sclerosis and may enable killing of EBV+ cells believed to be a contributing factor in this disease Data suggests a potential therapeutic role for AIM multi-antigen-specific products in mul...
2023-05-16 03:56:53 ET Neximmune press release ( NASDAQ: NEXI ): Q1 GAAP EPS of -$0.37. Cash and cash equivalents for the Company as of March 31, 2023 were $22.3 million compared to $34.6 million at December 31, 2022. Based upon current operating plans, NexIm...
Company has initiated pre-IND discussions with the FDA for its first AIM INJ indication NEXI-001 Phase I data to be presented at ASCO 2023 in June GAITHERSBURG, Md., May 15, 2023 (GLOBE NEWSWIRE) -- NexImmune, Inc. (Nasdaq: NEXI), a biotechnology company developing a novel appro...
GAITHERSBURG, Md., April 26, 2023 (GLOBE NEWSWIRE) -- NexImmune, Inc. (Nasdaq: NEXI), a biotechnology company developing a novel approach to immunotherapy designed to orchestrate a targeted immune response by directing the function of antigen-specific T cells for liquid and solid malignancies, to...
2023-03-28 17:06:22 ET Neximmune press release ( NASDAQ: NEXI ): Q4 GAAP EPS of -$2.60. Cash, cash equivalents and marketable securities for the Company as of December 31, 2022 were $34.6 million For further details see: Neximmune GAAP EPS of -$2.60
Company has initiated pre-IND discussions with the FDA for its first AIM INJ indication NEXI-001 completed enrollment in its final safety cohorts and all patients have been dosed; Company continues to follow patients and will announce data at or around an upcoming scientific conference ...
3 Ways to Identify Penny Stock Trends Penny stocks can offer significant upside potential for investors who are willing to take on some risk. However, penny stocks can also be highly volatile, which makes it challenging to identify trends and make informed investment decisions. For this r...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: MagioreStock / Shutterstock.com Wix (NASDAQ: WIX ) layoffs are on the way as the Israeli software company reveals another batch of job cuts . The newest Wix layoffs have the company cutting 370 jobs out o...
News, Short Squeeze, Breakout and More Instantly...
A look at the top 10 most actives in the United States Onconetix Inc. (ONCO) rose 46.5% to $0.2183 on volume of 404,016,812 shares NVIDIA Corporation (NVDA) rose 2.6% to $121.09 on volume of 317,123,916 shares PROSHARES TRUST (SQQQ) rose 1.5% to $8.23 on volume of 207,449,647 shares Max...
A look at the top 10 most actives in the United States Onconetix Inc. (ONCO) rose 113.3% to $0.3178 on volume of 162,323,665 shares NVIDIA Corporation (NVDA) rose 0.8% to $118.92 on volume of 44,858,282 shares Maxeon Solar Technologies Ltd. (MAXN) rose 8.5% to $0.2648 on volume of 43,008,...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 6.6% to $117.99 on volume of 383,510,118 shares Aptevo Therapeutics Inc. (APVO) rose 73.4% to $0.581 on volume of 315,289,581 shares PROSHARES TRUST (SQQQ) rose 8.7% to $8.11 on volume of 173,682,364 sha...